--- title: XtalPi slug: xtalpi-ca4b6 url: /detay/xtalpi-ca4b6 type: article language: English entity: primary: XtalPi type: article categories: - name: Science And Technology slug: bilim url: /kategori/bilim - name: Engineering slug: muhendislik url: /kategori/muhendislik - name: Technology And Innovation slug: teknoloji url: /kategori/teknoloji tags: - XtalPi author: Ömer Said Aydın created_at: 2025-10-25T21:08:23.963355+03:00 updated_at: 2025-11-02T14:33:01.407608+03:00 image: https://cdn.t3pedia.org/media/uploads/2025/10/25/qXBpCi9xqO031cpue1Ns1mmnlUAwl9G4.webp --- # XtalPi ## KURE Information Cards ![P9HMfeApIapMP8kvdkGYWE1dk7dqC1RU.webp](https://cdn.t3pedia.org/media/uploads/2025/10/25/G9mCwISyBjJuFGvGDldepJPqwHNHz1EO.webp) *XtalPi* | Field | Value | |-------|-------| | Website(s) | https://www.xtalpi.com | | Founded(Text) | 2015 | | Headquarters | Boston, Massachusetts, USA | ## Article Content **XtalPi** is a technology company that integrates **quantum physics–based computational methods, artificial intelligence,** and **robotic automation** to accelerate and scale drug research and development. Operating across China and the United States, the company coordinates computational and experimental resources to meet the needs of clients and collaborators. Its iterative feedback loop between **in silico (dry lab)** modeling and **wet-lab** experimentation enables continuous optimization through **cloud supercomputing** and **autonomous laboratory systems**. ### **Foundation and Growth** Founded in **2015** in **Boston, Massachusetts** by three MIT postdoctoral physicists, [XtalPi](/en/detay/xtalpi-f06f0/llms.txt) began with crystal structure prediction and solid-state analysis services. The accuracy of its **crystal structure prediction (CSP)** platform—validated in a blind test by **Pfizer**—led to collaborations in solid-form selection and polymorph screening, contributing to the solid-state development of **nirmatrelvir (Paxlovid)** during the COVID-19 pandemic. Between **2016 and 2024**, XtalPi established an **AI R&D center**, launched the **XtalPi Force Field (XFF)** and **Free Energy Perturbation (XFEP)** solutions, opened **wet labs** for solid-state and synthesis research, developed **autonomous laboratory prototypes**, and expanded with a **computational R&D center in Shenzhen** and a **pharmaceutical hub in Shanghai**. It also created the **XupremAb** antibody discovery platform, deployed **robotic smart network laboratories**, and opened a **demo lab in Boston**. In **2024**, the company expanded automation to **chemistry, traditional Chinese medicine, and materials development** and was **listed on the Hong Kong Stock Exchange**. XtalPi employs **over 1,000 staff**, holds **160+ granted patents**, maintains **80+ partnerships** across academia, pharma, and biotech, and operates **10,000+ m²** of lab space. ### **Technology Platform** XtalPi’s hybrid **AI + Quantum Mechanics (AI+QM)** platform combines cloud-based **GPU parallel computing** with **free energy perturbation (FEP)** and **force-field modeling** to predict **binding free energies, crystal structures,** and **drug-like properties**. Experimental data from synthesis, screening, and characterization are fed back into active learning cycles for model refinement. Key technologies include: - **XMolGen** – generative chemistry platform enabling virtual screening, synthetic feasibility assessment, and candidate prioritization. - **XFEP** – scalable FEP engine performing thousands of binding free energy calculations weekly. - **PatSight** – NLP and optical extraction of chemical, activity, and ADMET data from patents and literature for SAR analysis. - **XFF** – high-accuracy force-field computation system. - **XtalGazer** – crystal structure prediction and polymorph analysis tool. - **ProteinGPT** – proprietary large language model for protein design and biological sequence understanding. XtalPi’s **digital chemistry pipeline** integrates intellectual property analysis, data fusion, generative molecular design, and rapid **Design–Make–Test–Analyze (DMTA)** loops through robotic synthesis and active learning. In structural biology, the company applies **cryo-EM** and **micro-ED** to elucidate binding modes, polymorphism relationships, and solid-state transitions. Demonstrated achievements include: - Identification of potent noncovalent GPX4 hits within 28 days. - Discovery of flexible allosteric scaffolds using XMolGen + XFEP. - Structural studies on **clotrimazole**, **ketoprofen**, and **nirmatrelvir** polymorphs. - Mechanistic elucidation of **SARM1** via cryo-EM. ### **Organization and Culture** The company is led by **Shuhao Wen** (Chairman & Co-founder), **Jian Ma** (CEO & Co-founder), and **Lipeng Lai** (Chief Innovation Officer & Co-founder). Its culture emphasizes **market orientation**, **data-driven validation**, and **customer-focused process optimization**. XtalPi has been recognized in **Forbes China Enterprise Technology 50**, **Deloitte China Technology Fast 50**, **CB Insights Digital Health 150**, **MIT Technology Review China 50 Smartest Companies**, and **36Kr AI Top 50**. ### **Collaborations** XtalPi collaborates with major **pharmaceutical** and **biotechnology companies** in polymorph screening, solid-form selection, computational modeling, DEL/HTS assays, and structural characterization. Its software components are available through **cloud** or **on-premise** deployment, and its **robotic wet-lab systems** are adapted for chemical and materials R&D. By connecting **AI+QM computation** with **robotic experimentation**, XtalPi institutionalizes a **data-driven feedback cycle** between dry and wet labs. Integrating patent mining, generative design, free energy computation, structural biology, and solid-state science, the company provides a unified **R&D pipeline** from **target discovery** to **solid-form selection**, aiming to enhance the **speed, scale,** and **quality** of drug development. ## Academic Sources and References 1. XtalPi. “About.” Official Website. Accessed October 24, 2025. https://en.xtalpi.com/about/.XtalPi. “Digital Chemistry.” Official Website. Accessed October 24, 2025. https://en.xtalpi.com/digital-chemistry/.XtalPi. “Drug Discovery.” Official Website. Accessed October 24, 2025. https://en.xtalpi.com/drug-discovery/.XtalPi. “Home.” Official Website. Accessed October 24, 2025. https://en.xtalpi.com/.XtalPi. “PatSight.” Official Website. Accessed October 24, 2025. https://en.xtalpi.com/patsight/.XtalPi. “Technology.” Official Website. Accessed October 24, 2025. https://en.xtalpi.com/technology/.XtalPi. “XFEP.” Official Website. Accessed October 24, 2025. https://en.xtalpi.com/xfep/.XtalPi. “XMolGen.” Official Website. Accessed October 24, 2025. https://en.xtalpi.com/xmolgen/.XtalPi. “About.” LinkedIn. Accessed October 24, 2025. https://www.linkedin.com/company/xtalpi/.